In an IRB approved 10-patient retrospective study¹, the authors assessed the clinical effectiveness and healing characteristics of the Geistlich Derma- Gide®. Additional data was collected on the average cost to treat each patient as well as unique handling and performance characteristics of the product.
Continuous Clinical Research
Geistlich has a long history of clinical research supporting the effectiveness and performance of their products.
Randomized controlled prospective clinical study to compare Geistlich Derma-Gide® vs Standard of Care in the treatment of Diabetic Foot Ulcers
Patient information: 81-year-old Male with Diabetes mellitus
2.5 cm × 2 cm lateral plantar Diabetic Foot Ulcer with wound edge maceration | Wagner grade 1 | One month of unsuccessful treatment with Standard of Care | Significant progression/healing after 5 weeks of Geistlich Derma-Gide® treatment
Patient information: 43-year-old Male with Diabetes mellitus
5 cm × 3 cm distal Diabetic Foot Ulcer with exposed bones | Wagner grade 2 | Two months of unsuccessful treatment with Standard of Care | Significant progression/healing after 6 weeks of Geistlich Derma-Gide® treatment